Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ibio Inc (NYSE MKT LLC:IBIO)

0.72
Delayed Data
As of Jun 30
 +0.035 / +5.11%
Today’s Change
0.45
Today|||52-Week Range
0.98
+28.57%
Year-to-Date
No recent news for Ibio Inc.

Today’s Trading

Previous close0.69
Today’s open0.69
Day’s range0.69 - 0.80
Volume993,361
Average volume (3 months)163,968
Market cap$61.0M
Dividend yield--
Data as of 06/30/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+802.93%
P/E ratioNM
Price/Sales36.69
Price/Book4.71

Competitors

 Today’s
change
Today’s
% change
EVOKEvoke Pharma Inc-0.13-1.86%
ISRIsoRay Inc-0.04-4.40%
MTPMidatech Pharma PLC0.000.00%
CYANCyanotech Corp+0.02+0.39%
Data as of 06/30/2016

Financials

Last reporting dateAugust 29, 2012
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$1.9M
Annual profit (last year)-$6.6M
Net profit margin-357.91%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Robert B. Kay
President
Robert L. Erwin
Corporate headquarters
Newark, Delaware

Forecasts

Partner Offers

Search for Jobs